Evidence map›Paper›PMID 26567214›Full record

ArticleJournal of cell science2016

Reciprocal regulation of alternative lineages by Rgs18 and its transcriptional repressor Gfi1b.

Ananya Sengupta, Ghanshyam Upadhyay, Sayani Sen, Shireen Saleque

Abstract read
In one paragraph

Article in Journal of cell science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Mechanisms of Thrombocytosis in Iron-Deficiency Anemia.European journal of haematology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ananya SenguptaDept. of Biology, The City College of New York and The Graduate Center of The City University of New York, 160 Convent Avenue, New York, NY 10031, USA.
Ghanshyam UpadhyayDept. of Biology, The City College of New York and The Graduate Center of The City University of New York, 160 Convent Avenue, New York, NY 10031, USA.
Sayani SenDept. of Biology, The City College of New York and The Graduate Center of The City University of New York, 160 Convent Avenue, New York, NY 10031, USA.
Shireen SalequeDept. of Biology, The City College of New York and The Graduate Center of The City University of New York, 160 Convent Avenue, New York, NY 10031, USA ssaleque@ccny.cuny.edu.
The Graduate Center, CUNY · USCity College of New York · US

Funding

TNC FUNCTION IN APOPTOTIC ANTIGEN DRIVEN AUTOIMMUNITYG12RR003060 · NCRR · CITY COLLEGE OF NEW YORK · PI WALLMAN, JOSHUA · 1985 to 2011
$26.1M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Genetic and Epigenetic Regulation of Hematopoiesis.SC1HL104638 · NHLBI · CITY COLLEGE OF NEW YORK · PI SALEQUE, SHIREEN · 2010 to 2014
$1.9M
NCRR NIH HHS G12 RR003060NCRR NIH HHS G12RR03060-26A1NHLBI NIH HHS 5SC1HL104638NHLBI NIH HHS SC1 HL104638NIMHD NIH HHS 8G12MD007603-27NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

Appropriate diversification of cellular lineages from multi-potent progenitors is essential for normal development and homeostasis. The specification of erythroid and megakaryocytic lineages represents an especially vital developmental event whose molecular regulation remains incompletely defined. We now demonstrate the role of Rgs18, a GTPase-activating protein and transcriptional target of the repressor Gfi1b, in regulating these processes in mouse and human cells. Gfi1b stringently represses Rgs18 expression in erythroid cells, whereas, during megakaryocytic differentiation, declining Gfi1b levels facilitate a robust induction of Rgs18. Concordantly, alterations in Rgs18 expression produce disparate outcomes by augmenting megakaryocytic and potently suppressing erythroid differentiation and vice versa. These phenotypes reflect the differential impact of Rgs18 on signaling through p38 MAPK family proteins, and ERK1 and ERK2 (also known as MAPK3 and MAPK1, respectively) in the two lineages, which in turn alter the balance between the mutually antagonistic transcription factors Fli1 and Klf1. Overall, these results identify Rgs18 as a new and crucial effector of Gfi1b that regulates downstream signaling and gene expression programs to orchestrate erythro-megakaryocytic lineage choices. This dual role of Rgs18 in reciprocally regulating divergent lineages could exemplify generic mechanisms characteristic of multiple family members in different contexts.

Indexed as

Cell LineageAnimalsCell DifferentiationCell LineErythroid CellsHistone DemethylasesKruppel-Like Transcription FactorsMAP Kinase Signaling SystemMegakaryocytesMiceProto-Oncogene Protein c-fli-1Proto-Oncogene ProteinsRepressor ProteinsRGS ProteinsTranscription, Geneticerythroid Kruppel-like factorFli1 protein, mouseGfi1b protein, mouseHistone DemethylasesKDM1a protein, mouseKruppel-Like Transcription FactorsProto-Oncogene Protein c-fli-1Proto-Oncogene ProteinsRepressor ProteinsRgs18 protein, mouseRGS ProteinsDifferentiationSignalingTranscription

Identifiers

PMID26567214
PMCPMC4732296
OpenAlexW2179561152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.